5. The Downfall

The '5. The Downfall' episode of 'The Dropout' podcast delves into the unraveling of Elizabeth Holmes and her company Theranos following the explosive Wall Street Journal reports by John Carreyrou. Despite the mounting evidence of discrepancies and inaccuracies in Theranos's blood-testing technology, Elizabeth remains defiant, rallying her employees and making public appearances to defend her company. However, the departure of Sunny Balwani, the president and COO of Theranos and Elizabeth's romantic partner, signals the beginning of the end. His exit coincides with the internal restructuring of the company and reflects the tumultuous times Theranos is facing.

As the episode unfolds, it becomes apparent that the once-lauded technology of Theranos is under intense scrutiny. Venture capitalist Tim Draper, one of Theranos's early supporters, continues to defend Elizabeth vehemently, even after the Wall Street Journal's revelations. The narrative also touches on Channing Robertson, a Stanford professor and early Theranos backer, who, despite his deep involvement, remains a believer in the company's mission. Meanwhile, Walgreens, a key business partner, terminates its contract with Theranos, leading to a slew of lawsuits from investors and patients alike. The company is also forced to void tens of thousands of test results, further eroding its credibility.

The episode paints a picture of Elizabeth Holmes's deposition, where she frequently responds with uncertainty or a lack of recollection, a stark contrast to her previous image as a confident and knowledgeable CEO. The deposition reveals that many of Theranos's claims about its technology and capabilities were overstated or outright false. The company's failure to disclose its reliance on third-party devices for testing and its inability to scale its technology are highlighted as significant factors in its downfall.